Is nitric oxide the forgotten nephroprotective treatment during cardiac surgery?
- PMID: 32052208
- PMCID: PMC7016086
- DOI: 10.1186/s13613-020-0631-7
Is nitric oxide the forgotten nephroprotective treatment during cardiac surgery?
Conflict of interest statement
ML received research funding from the French ministry of health, research support from Sphingotec, lecture fees from Fresenius and Baxter and consulting fees from Novartis. The other authors declare that they have no competing of interests.
Figures
References
-
- Vermeulen Windsant IC, de Wit NCJ, Sertorio JTC, van Bijnen AA, Ganushchak YM, Heijmans JH, et al. Hemolysis during cardiac surgery is associated with increased intravascular nitric oxide consumption and perioperative kidney and intestinal tissue damage. Front Physiol. 2014;5:340. doi: 10.3389/fphys.2014.00340. - DOI - PMC - PubMed
